Target intelligence / Profile preview

Long intergenic non-protein coding RNA 412 (LINC00412)

Target
LINC00412
Molecular classification
Long non-coding RNA (lncRNA), Other (lncRNA family)
01

Overview

LINC00412 (long intergenic non-protein coding RNA 412) is a human long non-coding RNA gene located on chromosome 13, involved primarily in the regulation of gene expression and cellular behavior. High expression levels of LINC00412 are consistently associated with reduced breast cancer tumor grade, estrogen receptor positivity, favorable molecular subtypes, and improved patient survival; these findings are supported by large clinical datasets and experimental evidence. LINC00412 acts as a tumor suppressor, and its expression is regulated predominantly by promoter DNA methylation rather than copy number variation. While its utility lies in its potential as a prognostic biomarker for breast cancer, especially grade 2 tumors, it is not considered a pharmacologically actionable target and thus has no known drug interactions or safety concerns relating to direct clinical targeting.

Other names
LINC00412LINC02340
02

Mechanism of action

Not applicable. No drugs are known to act on this molecule directly.

03

Biological functions

Regulation of cell growthInhibition of cell migrationTumor suppressionOther (gene expression regulation via epigenetic mechanisms, e.g., DNA methylation)
04

Disease associations

Cancer (particularly breast cancer, demonstrated tumor-suppressive effects and prognostic value)
05

Safety considerations

None reported directly; no therapeutic interventions currently target LINC00412, so no safety concerns are established
06

Biomarkers

Expression level of LINC00412 serves as a biomarker for breast cancer prognosis, especially for distinguishing survival differences among patients with grade 2 tumors

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 412 (LINC00412).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 412 (LINC00412).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call